Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Article in English | MEDLINE | ID: mdl-31605583

ABSTRACT

Porous metal augments have been used successfully for management of large acetabular defects during revision hip arthroplasty. This study analyzes and compares the clinical and radiographic outcomes of porous metal augments in cemented and uncemented acetabular revisions, all performed at the same institution. In the period 2015-2017, 36 patients with 37 large acetabular defects were treated with porous metal augments in cemented and uncemented acetabular revisions. Postoperatively, patients were monitored for two years on average period of 24-36 months. Acetabular augments were used when preoperative and intraoperative findings indicated the presence of large acetabular defects that can hinder the stability of the revision implants. We used lateral approach, 36 mm femoral head, and cementless or cemented acetabular cup depending on local bone quality. Postoperatively, all patients followed total hip arthroplasty precautions, with weight bearing as tolerated regimen with use of crutches during 6 weeks after surgery. The follow-up was radiological and clinical. We used HHS. At a mean follow-up of two years (range 24-36 months) one patient had reinfection and one patient had infection. None of the patients shown signs of aseptic augment or acetabular cup loosening. Porous metal augments show comparable excellent radiographic and clinical short-term outcomes, when combined with cemented or uncemented cups in revision hip arthroplasty. They allow good bone ingrowth, adequate implant contact and good stability. Complications were related to infection and not related to the augments itself.


Subject(s)
Acetabulum/abnormalities , Acetabulum/surgery , Arthroplasty, Replacement, Hip/instrumentation , Reoperation/methods , Acetabulum/diagnostic imaging , Aftercare , Aged , Arthroplasty, Replacement, Hip/methods , Bone Cements/adverse effects , Cementation/trends , Female , Hip Prosthesis , Humans , Male , Metals/adverse effects , Middle Aged , Porosity , Postoperative Complications/epidemiology , Prosthesis Design , Radiography/methods , Reoperation/instrumentation , Treatment Outcome
3.
Article in English | MEDLINE | ID: mdl-27442385

ABSTRACT

The revision of the two phase treatment represents a golden standard in the treatment of infected endoprosthesis. Throughout this study, the results of 21 patients with an infected hip endoprosthesis treated in two phases have been processed, with the use of an antibiotic spacer, within the period of 2009 and 2012. Thereby, a unique protocol for diagnosis and treatment of infections has been applied to all the patients, which entails a preoperational x-ray image, laboratory findings (Se, CRP), as well as a puncture aspiration with a microbiological and biochemical examination of the aspirated fragments. The operational treatment consists of: taking a sample for microbiological and histopathological diagnosis, removal of the implanted endoprosthesis, excision of the avascular and necrotic tissue and installing an antibiotic spacer. Postoperatively, the patients are treated with a parenteral application of an antibiotics based on an antibiogram, throughout a period of two weeks, and later on an oral treatment, a combination of two antibiotics, depending on the antibiogram, within the following four to six weeks. After the appeasement of the local findings and the laboratory results, a revision with a removal of the antibiotic spacer and reimplantation of an endoprosthesis - revisional or primary has been conducted on the patients, depending on the bone deficit. The functionality of the joint is graded based on the Haris Hip Score. The patients are being observed postoperatively for a period of 12 to 36 months. A definite reimplantation has been applied to 20 patients, while one patient has been treated with a resection method. The Haris Hip Score was 45 preoperatively, and 80 postoperatively. The applied protocol of the treatment of infected endoprosthesis is effective in the eradication of the infection and the final reimplantation.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Arthroplasty, Replacement, Hip/adverse effects , Coated Materials, Biocompatible , Debridement , Device Removal , Hip Joint/surgery , Hip Prosthesis/adverse effects , Prosthesis-Related Infections/surgery , Adult , Aged , Arthroplasty, Replacement, Hip/instrumentation , Debridement/adverse effects , Device Removal/adverse effects , Drug Administration Schedule , Female , Hip Joint/pathology , Hip Joint/physiopathology , Humans , Male , Middle Aged , Necrosis , Prosthesis Design , Prosthesis-Related Infections/diagnosis , Prosthesis-Related Infections/microbiology , Reoperation , Time Factors , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...